Amendment AGREEMENTAmendment Agreement • June 17th, 2024 • MyMD Pharmaceuticals, Inc. • In vitro & in vivo diagnostic substances
This Amendment Agreement (this “Agreement”), dated as of June 17, 2024, is by and between MyMD Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the investor listed on the signature page attached hereto (the “Investor”).
GENERAL RELEASE AND SEVERANCE AGREEMENTGeneral Release and Severance Agreement • June 17th, 2024 • MyMD Pharmaceuticals, Inc. • In vitro & in vivo diagnostic substances • Maryland
This General Release and Severance Agreement (the “Agreement”), dated as of June 14 2024 is made and entered into by and between Chris Chapman, M.D. (“Employee”) and MyMD Pharmaceuticals, Inc. (the “Company”).
